Ergomed PLC (LSE:ERGO) - Share price - Overview

Stock Report

Ergomed PLC ERGO

Last Price
GBX242.00

Day Change
13.00|5.68%

As of 25/05/2018
17:15:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close229.00p
Day Range230.00 - 244.00
Mkt Cap108.40Mil
52-Wk Range163.10 - 300.00
Yield %-
ISINGB00BN7ZCY67
Volume139,414
P/E-68.38
P/S0.02
P/CF40.33

Share Price

Total Returns 25/05/2018

 Chg (%)  
More ...
Ergomed PLC15.24 
FTSE 100 TR GBP5.34
 
Financials
201520162017
More ...
Income Statement
Turnover30.1839.2347.62
Operating Profit2.380.81-0.63
Net Profit1.55-0.07-4.50
Reported EPS5.20-0.20-11.00
Balance Sheet
Current Assets13.5019.6222.97
Non Current Assets11.1934.5638.94
Total Assets24.6954.1961.91
Current Liabilities7.238.5913.86
Total Liabilities7.7619.7927.07
Total Equity16.9434.4034.84
Cash Flow
Operating Cash Flow0.85-1.430.38
Net Change in Cash-0.600.45-1.21

Regulatory News

DateSourceHeadline
More ...
24/05/2018|16:00RNSErgomed plc - Holding(s) in Company
21/05/2018|15:35RNSErgomed plc - Notice of AGM
02/05/2018|07:00RNSErgomed plc - Holdings in Company
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/05/2018PurchaseDr. Jan Petracek187.2550,40994,391.00
16/04/2018SaleDr. Miroslav Reljanovic190.004,000,0007,600,000.00
01/02/2018PurchaseMr. Peter Lutz George190.00500,000950,000.00
01/02/2018SaleDr. Miroslav Reljanovic190.00500,000950,000.00

Company Profile

Ergomed PLC is engaged in providing services to the pharmaceutical industry and develops new drugs. The company operates in two business divisions namely Clinical Research Services and Drug Safety and Medical Information Services.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 12/06/2018

Annual General Meeting
Ratios
Comp
More ...
PER (E)525.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-9.25
Op Mrgn-0.01
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Peter Lutz George
Executive Director, Vice ChairmanDr. Miroslav Reljanovic
Executive Director, Chief Operating OfficerDr. Jan Petracek
Non-Executive DirectorMr. Christopher Collins
Executive Director, Chief Executive Officer, PrimeVigilanceMr. Neil Robert Clark
Executive Director, Chief Executive OfficerStephen Anthony Stamp
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.